Form D · Other Health Care
Reflux Co
Bremerton, WA · CIK 0002127592
Offering snapshot reported May 22, 2026 · SEC filing
- Reported sold
- $525K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 6, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2026 | Initial | $525,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-584964
Source: Form D, filed May 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Ball | Director, Executive, Promoter |
| Daniel Capuano | Director |
| Richard Mockler | Director |
| Shaun O'neil | Director |
| Bert Sutter | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
509 4 Th Street Ste 43
Bremerton, WA, 98337
Bremerton, WA, 98337